Showing 1 – 4 of 4
Relevance | Newest | Oldest |
  • Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

    Abstract Full Text
    online first
    JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578

    This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.

  • Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction

    Abstract Full Text
    free access online only
    JAMA Surg. 2022; 157(6):e220631. 10.1001/jamasurg.2022.0631

    This comparative effectiveness research study compares long-term quality-of-life outcomes in women with breast cancer after treatment with breast-conserving surgery and radiation therapy vs mastectomy and reconstruction without radiation therapy.

  • Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery

    Abstract Full Text
    free access
    JAMA Surg. 2017; 152(7):665-670. 10.1001/jamasurg.2017.0562

    This cohort study identifies patients with breast cancer and a pathologic complete response to neoadjuvant chemotherapy with a low risk for axillary metastases and possibly eligible for omission of surgery.

  • Selective Surgical Localization of Axillary Lymph Nodes Containing Metastases in Patients With Breast Cancer: A Prospective Feasibility Trial

    Abstract Full Text
    free access
    JAMA Surg. 2015; 150(2):137-143. 10.1001/jamasurg.2014.1086

    This prospective feasibility trial adds selective removal of clip-containing lymph nodes to sentinel lymph node dissection, with the possibility of identifying patients for limited nodal surgery after chemotherapy.